Trademark: 79186612
Word
JILUNAR
Status
Dead
Status Code
404
Status Date
Monday, April 22, 2019
Serial Number
79186612
Registration Number
5033991
Registration Date
Tuesday, September 6, 2016
Mark Type
4000
Filing Date
Friday, February 19, 2016
Published for Opposition
Tuesday, June 21, 2016
Cancellation Date
Monday, April 22, 2019

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Nov 15, 2019
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Nov 15, 2019
Death Of International Registration
Jul 21, 2017
Notification Processed By Ib
Feb 10, 2017
Notification Processed By Ib
Oct 13, 2016
Final Disposition Notice Sent To Ib
Oct 13, 2016
Final Disposition Processed
Oct 6, 2016
Grant Of Protection Created, To Be Sent To Ib
Sep 6, 2016
Registered-Principal Register
Jun 21, 2016
Published For Opposition
Jun 1, 2016
Notification Of Possible Opposition Sent To Ib
Jun 1, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 1, 2016
Notice Of Publication
May 16, 2016
Approved For Pub - Principal Register
May 13, 2016
Application Filing Receipt Mailed
May 9, 2016
Assigned To Examiner
May 9, 2016
New Application Office Supplied Data Entered In Tram
May 6, 2016
Limitation From Original Application Entered
May 5, 2016
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24